Crossmark

4-Acetylantroquinonol B inhibits lipopolysaccharide-induced cytokine release and alleviates sepsis through of MAPK and NFκB suppression

Crossref DOI link: https://doi.org/10.1186/s12906-018-2172-2

Published Online: 2018-03-23

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chang, Chien-Hsin

Hsu, Chun-Chieh

Lee, An-Sheng

Wang, Shih-Wei

Lin, Kung-Tin

Chang, Wei-Luen

Peng, Hui-Chin

Huang, Wen-Chiung

Chung, Ching-Hu https://orcid.org/0000-0002-3096-8974
Funding

Funding for this research was provided by:

Ministry of Science and Technology, Taiwan (102-2320-B-715-002-MY2)

Mackay Medical College (MMC-1031A02, 1042E01, 1051C01, 1051E01, 1051B08, 1061E02 and 1061B22)
License Information

Text and Data Mining valid from 2018-03-23
More Information

Article History

Received: 23 December 2016

Accepted: 15 March 2018

First Online: 23 March 2018

Ethics approval

: All the experimental protocols regarding animal studying have been approved by the Laboratory Animal Use Committee of MacKay Medicine College.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.